Trial Information
High Frequency Ultrasound and Contrast Enhanced Ultrasound of Patients Treated for Deterioration of Crohn's Disease
Inclusion Criteria:
- Deterioration of Crohn's disease
- CDAI>150
- Treated with systemic steroids or TNF alfa inhibitors
- Lesion found on ultrasound
Exclusion Criteria:
- Disease location not reachable with ileocolonoscopy
- Pregnancy
- Acute coronary disease
- Unstable coronary disease
- Previous allergic reaction to SonoVue or its components
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
Remission defined by Crohns disease activity index (CDAI)<150
Outcome Time Frame:
52 weeks from inclusion
Safety Issue:
No
Principal Investigator
Trygve Hausken, PhD
Investigator Role:
Study Director
Investigator Affiliation:
Nastional Center of Gastroenterological Ultrasonography, Haukeland University Hospital, Bergen, Norway
Authority:
Norway:National Committee for Medical and Health Research Ethics
Study ID:
22209
NCT ID:
NCT01074580
Start Date:
November 2009
Completion Date:
December 2014
Related Keywords:
- Crohn's Disease
- Crohn's disease
- sonography
- contrast enhanced ultrasound
- Crohn Disease